Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_4
5
42%
Ph phase_3
5
42%
Ph phase_2
2
17%

Phase Distribution

0

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
5(41.7%)
Phase 4Post-market surveillance
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(7)
Terminated(1)
Other(4)

Detailed Status

Completed7
unknown4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (16.7%)
Phase 35 (41.7%)
Phase 45 (41.7%)

Trials by Status

unknown433%
withdrawn18%
completed758%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12